Multiple Sclerosis Drugs Market Outlook and Strategic Business Report 2024-2030: Increased Awareness and Diagnosis Rates Boosting Treatment Adoption
August 26, 2024 07:50 ET
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Multiple...
Multiple Sclerosis Drugs Market Outlook 2024-2028, 2033 - A $48 Billion Global Opportunity Dominated by Biogen, Novartis, Roche, Bayer HealthCare, and Pfizer
May 16, 2024 08:00 ET
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global multiple sclerosis drugs...
Global Multiple Sclerosis Treatment Market Report 2023: Sector is Projected to Reach $38.41 Million in 2031 at a CAGR of 4.3%
May 03, 2023 10:53 ET
|
Research and Markets
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global...
Multiple Sclerosis Drugs Market Size Forecast [2022-2028] | is Projected to Reach USD 41.99 Billion, Exhibiting a CAGR of 6.3 %
January 19, 2022 03:53 ET
|
Fortune Business Insights
Pune, India, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
North American MS Drugs Market, Forecast to 2027 by Drug Type, Class & Category; RoA; MS Type; Distribution Channel; and Country
December 15, 2021 08:53 ET
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "North America Multiple Sclerosis Drugs Market 2020-2027" report has been added to ResearchAndMarkets.com's offering. The North American multiple...
Global Multiple Sclerosis Drugs Market Report 2021: Market is Expected to Reach $25.95 Billion in 2025 - Long-term Forecast to 2030
December 13, 2021 06:53 ET
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Multiple Sclerosis Drugs Market (2020 to 2027) - Focus on Immunomodulators and Immunosuppressants
December 10, 2021 06:38 ET
|
Research and Markets
Dublin, Dec. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Drugs Market 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global multiple sclerosis drugs...
Multiple Sclerosis Drugs Market to Reach USD 41.99 Billion by 2028 | Market Projection By Technology, Major key players, Growth, Revenue, CAGR, Regional Analysis, Industry Forecast To 2028
November 08, 2021 03:56 ET
|
Fortune Business Insights
Pune, India, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
Multiple Sclerosis Drugs Market Size 2021-2028 | To Reach USD 41.99 Billion by 2028, Exhibiting a CAGR of 6.3 %
July 05, 2021 05:37 ET
|
Fortune Business Insights
Pune, India, July 05, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...
Multiple Sclerosis Drugs Market to Reach USD 41.99 Billion by 2028; Rising Support from Governments and Launch of Awareness Initiatives to Aid Growth: Fortune Business Insights™
June 10, 2021 07:34 ET
|
Fortune Business Insights
Pune, India, June 10, 2021 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...